Ocular Therapeutix (OCUL) Interest Expenses (2013 - 2026)
Ocular Therapeutix (OCUL) reported Interest Expenses of $2.79 million for Q2 2026, down 7.4% from $3.02 million a year earlier but up 0.5% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Interest Expenses (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ocular Therapeutix's Interest Expenses came in at $11.4 million, down 7.5% year-over-year; for FY2025, it was $11.84 million, down 12.8% from FY2024.
- Interest Expenses has a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- By year, Interest Expenses came in at $13.58 million in FY2024 (+19.7%), $11.34 million in FY2023 (+61.5%), $7.02 million in FY2022 (+5.3%) and $6.67 million in FY2021 (-1.4%).
- Five-year quarterly Interest Expenses spans a low of $1.66 million in Q3 2021 and a high of $4.15 million in Q4 2023.
- Year over year, Interest Expenses has now declined in each of the last eight quarters, with an average decline of 11.6% over the last eight quarters.
- The high point for year-over-year Interest Expenses in five years was Q1 2024 (growth of 129.1%); the low point was Q1 2025 (a decline of 26.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.78 million (Q1 2026), $2.83 million (Q4 2025) and $3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 2.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.79 Mn |
| Mar 31, 2026 | 2.78 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 3.11 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 4.15 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 1.99 Mn |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 1.80 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.68 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 1.66 Mn |
API Access
Ocular Therapeutix Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();